	Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases. Neurologia (Engl Ed) García Domínguez JM, María Villar L, Arrambide G, Blanco Y, Carmen Calles M, Casanova B, Castillo-Triviño T, Costa-Frossard França L, Eichau S, Hernández Pérez MÁ, Landete L, Meca Lallana J, Oreja-Guevara C, María Prieto J, Querol L, Belén Caminero A. PMID: 42044944 [PubMed - indexed for MEDLINE]
	Understanding late-stage clinical trial failure in multiple sclerosis: insights from ClinicalTrials.gov. Neuroepidemiology Rivero-de-Aguilar A, Pérez-Ríos M, Ross JS, Mascareñas-García M, Ruano-Raviña A, Varela-Lema L. PMID: 42044087 [PubMed - as supplied by publisher]
	Demyelinating disorders in women: epidemiology, immunology, and clinical implications across MS, NMOSD, and MOGAD. J Neurol Ind G, Hashmi Z, Ahuja S, Fayad T, Kahook Z, Ahmad R, Batool SM, Jiji KM, Hudli H, Hossain S, Lafi A, AbuJlambo A. PMID: 42043479 [PubMed - indexed for MEDLINE]
	Case Report: Improving gait and fatigue in multiple sclerosis through wearable electrical stimulation: a single-patient study. Front Rehabil Sci Filoni S, Romano F, Cardone D, Urbano S, Intiso D, Pellegrino R, Russo EF, Perpetuini D, Merla A. PMID: 42040650 [PubMed]
	Multimodal Neuroimaging and Electrophysiological Markers in Multiple Sclerosis: An Integrative Review of fMRI, EEG, and EMG Approaches : fMRI, EEG, EMG in Multiple Sclerosis. Galen Med J Salemi MH. PMID: 42038913 [PubMed]
	Machine learning for multiple sclerosis classification and disability prediction using clinical and MRI data. Front Artif Intell Valsasina P, Storelli L, Tedone N, Pantano P, Piervincenzi C, Tommasin S, Gallo A, Altieri M, Maggi G, De Stefano N, Bianchi A, Battaglini M, Mazzetti G, Pagani E, Rocca MA, Filippi M. PMID: 42038541 [PubMed]
	Physicians' Knowledge and Practice Regarding Multiple Sclerosis (MS) in Saudi Arabia: A Cross-Sectional Study. J Multidiscip Healthc Abdallah MS, Mahafdeh R, Alrubayyi BZ, AlRasheed HA. PMID: 42038104 [PubMed]
	Explainable Artificial Intelligence to Predict Neurocognitive Disorder Progression in Multiple Sclerosis Using MRI and Clinical Data. Eur J Neurol Storelli L, Mistri D, Mastropasqua A, Grosselle M, Preziosa P, Rossi L, Filippi M, Rocca MA. PMID: 42037489 [PubMed - indexed for MEDLINE]
	Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis. Clin Neurol Neurosurg Hamdy E, Talaat F, Ramadan I, Oertel FC, Bennett JL, Abousteit A, Almashad SS, Zeineddine M, Hassan A, Said SM, Contentti EC, Gaber D, Zakaria M, Ahmed S, Grigoriadis N, Fouda BH, Shalaby NM, Nasr N, Paul F, Zamzam D, Krupp L, Sayed A, Hassan SS, Naseer MA, Hegazy MI, Galeel AA, Elmesnshawy I, Salama S. PMID: 42035653 [PubMed - as supplied by publisher]
	Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administration. Mult Scler Grech L, Allan M, Skvarc D, Hamer R, Friedel E, Chong V, Giles A, Kulkarni J, Neil J, Rajendran D, John N, Short M, Shaw S, Caswell N, Fanning V, Butler E. PMID: 42035454 [PubMed - as supplied by publisher]
	Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparison. Mult Scler Hollen C, Garcia C, Hemond CC, Spain RI, Crowson C, Wu H, Silbermann E. PMID: 42035356 [PubMed - as supplied by publisher]
	7T magnetic resonance imaging of the human spinal cord in multiple sclerosis: Advances, insights and unmet needs. Rev Neurol (Paris) Callot V, Destruel A, Demortière S, Testud B. PMID: 42031644 [PubMed - as supplied by publisher]
	When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria? Curr Neurol Neurosci Rep Van Horebeek L, Das A, Neufeld J, Schneider R. PMID: 42029833 [PubMed - in process]
	Dental-amalgam exposure and the risk and progression of multiple sclerosis. Int J Epidemiol Guo J, Olsson T, Alfredsson L, Hedström AK. PMID: 42029353 [PubMed - indexed for MEDLINE]
	Effects of thoracic manipulation with trigger point therapy on inflammatory cytokine levels in individuals with multiple sclerosis: a pilot study. Front Rehabil Sci Alanazi MS, Motl RW, Jones BA, Qu H, Li P, Reed WR. PMID: 42028147 [PubMed]
	Natalizumab for pediatric multiple sclerosis: a systematic review and meta-analysis. Ther Adv Neurol Disord Ebne-Ali-Heydari Y, Ramezani A, Jozayi A, Norouzi M, Zohrabi P, Kaveyee H. PMID: 42027697 [PubMed]
	The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential. Rev Neurol (Paris) Bellucci G, Mechelli R, Bigi R, Ristori G, Salvetti M. PMID: 42025559 [PubMed - as supplied by publisher]
	Patient experiences with systematically-administered patient-reported outcome measures in multiple sclerosis. Mult Scler Relat Disord Desbiens V, Wong G, Liu S, Chu NY, Watson KE, Smyth P, Tsuyuki RT. PMID: 42025274 [PubMed - as supplied by publisher]
	Insights From Quantitative Susceptibility Mapping: An Umbrella Review of Multiple Sclerosis. Health Sci Rep Ghaderi S, Mohammadi S, Fatehi F. PMID: 42022641 [PubMed]
	Long-Term Clinical and Psychological Efficacy and Safety of Ocrelizumab in People With Multiple Sclerosis: A Real-World Longitudinal Study. Health Sci Rep Jafari M, Yazdan Panah M, Vaheb S, Adibi I, Ashtari F, Shaygannejad V, Zabeti A, Mirmosayyeb O. PMID: 42022617 [PubMed]

Articles 1 - 20 / 43845

Page 1 of 2193



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy